Bumrungrad Hospital Future Growth
Future criteria checks 2/6
Bumrungrad Hospital is forecast to grow earnings and revenue by 3.5% and 6.4% per annum respectively. EPS is expected to grow by 2.6% per annum. Return on equity is forecast to be 25.6% in 3 years.
Key information
3.5%
Earnings growth rate
2.6%
EPS growth rate
| Healthcare earnings growth | 9.9% |
| Revenue growth rate | 6.4% |
| Future return on equity | 25.6% |
| Analyst coverage | Good |
| Last updated | 21 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 29,648 | 8,203 | 7,880 | 9,476 | 15 |
| 12/31/2025 | 27,837 | 8,006 | 5,433 | 9,078 | 16 |
| 12/31/2024 | 25,867 | 7,677 | 7,441 | 8,597 | 13 |
| 9/30/2024 | 25,889 | 7,593 | 6,412 | 7,779 | N/A |
| 6/30/2024 | 26,211 | 7,592 | 6,757 | 8,283 | N/A |
| 3/31/2024 | 26,022 | 7,408 | 5,882 | 7,643 | N/A |
| 12/31/2023 | 25,547 | 7,006 | 5,419 | 7,094 | N/A |
| 9/30/2023 | 25,069 | 6,832 | 5,824 | 7,341 | N/A |
| 6/30/2023 | 24,038 | 6,378 | 5,436 | 7,032 | N/A |
| 3/31/2023 | 22,846 | 5,797 | 5,757 | 7,056 | N/A |
| 12/31/2022 | 20,908 | 4,938 | 4,992 | 6,213 | N/A |
| 9/30/2022 | 18,762 | 4,004 | 3,901 | 5,230 | N/A |
| 6/30/2022 | 16,012 | 2,799 | 3,500 | 4,506 | N/A |
| 3/31/2022 | 14,078 | 1,850 | 2,638 | 3,553 | N/A |
| 12/31/2021 | 12,605 | 1,216 | 2,587 | 3,556 | N/A |
| 9/30/2021 | 11,630 | 777 | 2,177 | 3,114 | N/A |
| 6/30/2021 | 11,554 | 702 | 2,212 | 3,157 | N/A |
| 3/31/2021 | 10,991 | 530 | 1,423 | 2,440 | N/A |
| 12/31/2020 | 12,440 | 1,204 | 1,268 | 2,261 | N/A |
| 9/30/2020 | 14,169 | 1,917 | 1,820 | 2,720 | N/A |
| 6/30/2020 | 16,057 | 2,751 | 1,291 | 3,102 | N/A |
| 3/31/2020 | 17,954 | 3,432 | 2,197 | 4,078 | N/A |
| 12/31/2019 | 18,559 | 3,748 | 3,012 | 4,897 | N/A |
| 9/30/2019 | 18,660 | 3,834 | 3,347 | 5,265 | N/A |
| 6/30/2019 | 18,620 | 3,908 | 4,101 | 5,027 | N/A |
| 3/31/2019 | 18,580 | 4,154 | 3,931 | 4,874 | N/A |
| 12/31/2018 | 18,541 | 4,152 | 3,840 | 4,734 | N/A |
| 9/30/2018 | 18,362 | 4,103 | 3,226 | 4,635 | N/A |
| 6/30/2018 | 18,435 | 4,029 | N/A | 4,611 | N/A |
| 3/31/2018 | 18,533 | 4,018 | N/A | 5,073 | N/A |
| 12/31/2017 | 18,272 | 3,944 | N/A | 5,243 | N/A |
| 9/30/2017 | 18,053 | 3,846 | N/A | 5,427 | N/A |
| 6/30/2017 | 17,857 | 3,756 | N/A | 5,652 | N/A |
| 3/31/2017 | 17,848 | 3,654 | N/A | 5,417 | N/A |
| 12/31/2016 | 18,103 | 3,626 | N/A | 5,174 | N/A |
| 9/30/2016 | 18,335 | 3,570 | N/A | 5,062 | N/A |
| 6/30/2016 | 18,076 | 3,448 | N/A | 4,267 | N/A |
| 3/31/2016 | 18,128 | 3,439 | N/A | 4,300 | N/A |
| 12/31/2015 | 17,883 | 3,436 | N/A | 3,987 | N/A |
| 9/30/2015 | 17,509 | 3,355 | N/A | 3,909 | N/A |
| 6/30/2015 | 17,248 | 3,280 | N/A | 4,075 | N/A |
| 3/31/2015 | 16,637 | 3,066 | N/A | 3,995 | N/A |
| 12/31/2014 | 15,864 | 2,730 | N/A | 3,890 | N/A |
| 9/30/2014 | 15,355 | 2,668 | N/A | 3,521 | N/A |
| 6/30/2014 | 14,973 | 2,603 | N/A | 3,634 | N/A |
| 3/31/2014 | 14,714 | 2,547 | N/A | 3,415 | N/A |
| 12/31/2013 | 14,597 | 2,521 | N/A | 3,274 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BH-R's forecast earnings growth (3.5% per year) is above the savings rate (2%).
Earnings vs Market: BH-R's earnings (3.5% per year) are forecast to grow slower than the TH market (17.8% per year).
High Growth Earnings: BH-R's earnings are forecast to grow, but not significantly.
Revenue vs Market: BH-R's revenue (6.4% per year) is forecast to grow slower than the TH market (6.9% per year).
High Growth Revenue: BH-R's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BH-R's Return on Equity is forecast to be high in 3 years time (25.6%)